Treatment of aplastic anemia

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/00 (2006.01) A61K 9/00 (2006.01) A61K 39/00 (2006.01)

Patent

CA 2662862

Methods of treating aplastic anemia in a patient and of increasing blood cell production in a patient having aplastic anemia are disclosed. The methods comprise administering to the patient a therapeutically effective amount of an IL-27 antagonist in combination with a pharmaceutically acceptable vehicle. IL-27 antagonists include soluble IL-27RA proteins and antagonists that comprise an antigen-binding site of an antibody.

L'invention a pour objet des procédés de traitement de l'anémie aplastique et d'accroissement de la production de globules sanguins chez un patient atteint d'anémie aplastique. Les procédés comprennent l'administration au patient d'une quantité thérapeutiquement efficace d'un antagoniste de l'IL-27 associé à un véhicule pharmaceutiquement acceptable. Les antagonistes de l'IL-27 comprennent des protéines solubles IL-27RA et des antagonistes qui comprennent eux-mêmes un site de liaison d'antigène d'un anticorps.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Treatment of aplastic anemia does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of aplastic anemia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of aplastic anemia will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1428598

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.